Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents

BACKGROUND: Although many acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients have been treated with hypomethylating agents (HMAs) as a substitute for intensive chemotherapy in recent years, the incidence of invasive fungal infections (IFIs) and the efficacy of posaconazole as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ka-Won, Lee, Byung-Hyun, Jeon, Min Ji, Yu, Eun Sang, Sik Kim, Dae, Lee, Se Ryeon, Sung, Hwa Jung, Choi, Chul Won, Park, Yong, Kim, Byung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832331/
https://www.ncbi.nlm.nih.gov/pubmed/35154623
http://dx.doi.org/10.1177/2040620720966882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832331/
https://www.ncbi.nlm.nih.gov/pubmed/35154623
http://dx.doi.org/10.1177/2040620720966882

Ejemplares similares